ODX.L Share News (ODX)
ODX Share
ODX Share
ODX Share
ODX Share
ODX
ODX Share
ODX Broker
ODX Directors
ODX Financial
ODX
ODX Short
ODXFri, 25th Nov 2022 11:33
(Sharecast News) - Omega Diagnostics confirmed the receipt of deferred consideration from the sale of the CD4 business on Friday.
The AIM-traded medical diagnostics company said it had now received the £4m of deferred consideration.
"Accordingly, as of close-of-business on 24 November, Omega held cash balances of £6.5m," the board said in its short statement.
At 1116 GMT, shares in Omega Diagnostics Group were up 10.83% at 3.99p.
Reporting by Josh White for Sharecast.com.
Medical diagnostics firm Omega Diagnostics is at its best levels since last October as acquisitions helped turnover jump 56% and profits more than double. The firm, which tests for specific infectious and autoimmune diseases, posted a pre-tax profit of £266,893 for the year ended 31 March 2009, up
Read moreRestaurant group Carluccio's said that it is no longer involved in discussions relating to a potential takeover of the company. Helius Energy, which installs biomass-powered renewable electricity generation plants, moved into profit in the half year to March 31 after selling its first project to R
Read more